Pretransplant Serum Hyaluronic Acid Can Be a Biomarker as a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation

Abstract Objective The goal of this study was to evaluate whether pretransplant serum hyaluronic acid (HA) levels can predict outcomes after adult-to-adult living donor liver transplantation (LDLT). Methods In study I, 21 patients who underwent LDLT (March 2002-February 2004) were divided into 2 gro...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2017-01, Vol.49 (1), p.102-108
Main Authors: Mizuno, S, Das, B.C, Iizawa, Y, Kato, H, Murata, Y, Tanemura, A, Kuriyama, N, Azumi, Y, Kishiwada, M, Usui, M, Sakurai, H, Isaji, S
Format: Article
Language:English
Subjects:
Adult
Biomarkers - blood
Female
Graft Survival
Humans
Hyaluronic Acid - blood
Liver Transplantation - mortality
Living Donors
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
Surgery
Survival Rate
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective The goal of this study was to evaluate whether pretransplant serum hyaluronic acid (HA) levels can predict outcomes after adult-to-adult living donor liver transplantation (LDLT). Methods In study I, 21 patients who underwent LDLT (March 2002-February 2004) were divided into 2 groups: the H-I group (HA ≥500 ng/mL; n = 12) and the L-I group (HA 
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2016.11.019